Rapport therapeutics to present at stifel healthcare conference and jefferies london healthcare conference in november

Boston and san diego, nov. 04, 2024 (globe newswire) -- rapport therapeutics, inc. (nasdaq: rapp), a clinical-stage biotechnology company focused on discovery and development of small molecule precision medicines for patients suffering from central nervous system (cns) disorders, today announced that management will participate in fireside chats at two upcoming investor conferences as follows:
RAPP Ratings Summary
RAPP Quant Ranking